Ram Palanki, PharmD
SVP of Commercial, Americas
Dr. Palanki brings more than 15 years of experience in ophthalmology across marketing, sales, reimbursement, commercial operations, business development, and medical affairs leadership. Prior to Santen, he was Global Head of Marketing and Sales at Thrombogenics, Inc., where he led the commercial launch for Jetrea®, a novel proteolytic enzyme therapy for Symptomatic VMA. Previously, Dr. Palanki served as Director of Global Marketing and Sales at NeoVista, Inc., and earlier in his career, held several positions at Genentech as part of the team that developed and launched Lucentis®. Prior to Genentech, he worked at Eyetech Pharmaceuticals as part of the initial team submitting the NDA for Macugen™ and at Novartis Pharmaceuticals in the New Product Commercialization group. Dr. Palanki earned his PharmD at Albany College of Pharmacy in New York and completed his postdoctoral fellowship at Rutgers University in New Jersey. Dr. Palanki also serves as a member of the American Glaucoma Society Advisory Board.
STAY UP TO DATE WITH OIS
Get the Latest News, Podcasts and Videos.